TY - JOUR
T1 - Percutaneous Anterograde Varicocele Embolization
T2 - Technique and Clinical Outcomes
AU - Kyaw Tun, Jimmy
AU - Le Tat, Thomas
AU - Hakime, Antoine
N1 - Publisher Copyright:
© 2024 SIR
PY - 2025/3/1
Y1 - 2025/3/1
N2 - Transcatheter retrograde testicular vein embolization for symptomatic varicoceles is well-established but has a documented failure rate. Percutaneous anterograde varicocele embolization may be a suitable alternative. A retrospective observational, descriptive study of consecutive patients who had undergone unsuccessful retrograde embolization attempts underwent percutaneous anterograde varicocele embolization at a single center was performed. Twenty patients (16 adults and 4 adolescents) underwent unilateral varicocele treatment. Technical success rate was 100%. Mean fluoroscopy time was 106.5 seconds (SD ± 24.9). For patients treated for subfertility, mean DNA fragmentation index significantly decreased from 29.4% (SD ± 4.5%) to 22.0% (SD ± 2.5%) preprocedurally and postprocedurally, respectively. No clinical or radiologic evidence of varicocele recurrence was detected at 1- and 2-year follow-up. Four patients (20%) experienced self-limiting pain. No major adverse events occurred. Percutaneous anterograde varicocele embolization appears to be safe with high technical and clinical success rates. Radiation dose may be lower than that with retrograde embolization.
AB - Transcatheter retrograde testicular vein embolization for symptomatic varicoceles is well-established but has a documented failure rate. Percutaneous anterograde varicocele embolization may be a suitable alternative. A retrospective observational, descriptive study of consecutive patients who had undergone unsuccessful retrograde embolization attempts underwent percutaneous anterograde varicocele embolization at a single center was performed. Twenty patients (16 adults and 4 adolescents) underwent unilateral varicocele treatment. Technical success rate was 100%. Mean fluoroscopy time was 106.5 seconds (SD ± 24.9). For patients treated for subfertility, mean DNA fragmentation index significantly decreased from 29.4% (SD ± 4.5%) to 22.0% (SD ± 2.5%) preprocedurally and postprocedurally, respectively. No clinical or radiologic evidence of varicocele recurrence was detected at 1- and 2-year follow-up. Four patients (20%) experienced self-limiting pain. No major adverse events occurred. Percutaneous anterograde varicocele embolization appears to be safe with high technical and clinical success rates. Radiation dose may be lower than that with retrograde embolization.
UR - http://www.scopus.com/inward/record.url?scp=85214348044&partnerID=8YFLogxK
U2 - 10.1016/j.jvir.2024.11.013
DO - 10.1016/j.jvir.2024.11.013
M3 - Article
C2 - 39586536
AN - SCOPUS:85214348044
SN - 1051-0443
VL - 36
SP - 467
EP - 471
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
IS - 3
ER -